Total planned funding: $92,138,182
Allocations
Countries/Regions
Burundi | $92,138,182 |
Organizational Types
NGO | $41,972,096 |
Private Contractor | $22,678,561 |
Unknown | $12,788,746 |
Own Agency | $10,219,598 |
University | $4,400,000 |
Other USG Agency | $79,181 |
Program Areas
Governance and Systems | $23,019,002 |
Prevention | $22,045,241 |
Treatment | $16,996,935 |
Testing | $12,692,095 |
Care | $10,863,074 |
Management and Operations | $6,521,835 |
Budget Codes
HVCT: Testing: HIV Testing and Counseling | $12,692,095 |
OHSS: Health Systems Strengthening | $12,180,240 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,792,193 |
HTXS: Treatment: Adult Treatment | $10,579,283 |
HVOP: Sexual Prevention: Other Sexual Prevention | $9,451,992 |
HVMS: Management and Operations | $6,521,835 |
HVSI: Strategic Information | $5,908,285 |
HKID: Care: Orphans and Vulnerable Children | $5,616,236 |
HLAB: Laboratory Infrastructure | $4,930,477 |
HBHC: Care: Adult Care and Support | $4,184,652 |
HTXD: Treatment: ARV Drugs | $3,949,508 |
PDTX: Treatment: Pediatric Treatment | $2,468,144 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,801,056 |
PDCS: Care: Pediatric Care and Support | $555,744 |
HVTB: Care: TB/HIV | $506,442 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
FHI 360:
$37,152,763
Countries/Regions
Not Available:
$11,611,200
Countries/Regions
Chemonics International:
$8,462,335
Countries/Regions
USG Aggregated Agencies:
$5,228,285
Countries/Regions